GN

Genus PLC (GNS)

HealthcareBiotechnology
2364.00GBX
-0.51%
Magic Rank
#300
Earnings Yield
2.8%
Return on Capital
39.8%
Market Cap
1.5B

Performance vs S&P 500 (5Y)

GNS.LSE
S&P 500

About Genus PLC

Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as technical services and advice under the PIC brand. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

Magic Formula Analysis

Enterprise Value1.7B
Market / Universe
gb
United Kingdom

"A company with high ROC and high EY is statistically more likely to outperform the market."

Key Indicators

P/E Ratio32.82
Dividend Yield1.4%
Debt to Equity0.39
Gross Margin14.5%